GlassScriptPhysician profile
Adam Shook
NPI 1346643806
$2,762.60
in general payments reported to CMS, 2019-2025
24 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $357 · 2022: $559 · 2023: $661 · 2024: $654 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $535.40 | 2021-2023 | Cabenuva, Apretude, Dovato |
| Gilead Sciences, INC. | $489.75 | 2021-2024 | Biktarvy |
| Organogenesis INC. | $453.33 | 2021-2025 | Puraply, Affinity, Apligraf |
| Smith+Nephew, INC. | $383.99 | 2021-2025 | Grafix Pl, Collagenase Santyl, Renasys Touch |
| Reddress USA, INC. | $235.87 | 2024 | |
| Reprise Biomedical, INC. | $95.76 | 2024-2025 | Miro3d, Miro 3d |
| Bioventus LLC | $78.83 | 2022 | |
| Janssen Biotech, INC. | $50.01 | 2022 | |
| Urgo Medical North America, LLC | $45.67 | 2025 | Urgoclean Ag |
| Mimedx Group, INC. | $41.12 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $40.43 | 2025 | |
| Abbvie INC. | $39.99 | 2024 | |
| Tactile Systems Technology INC | $31.64 | 2025 | Nimbl, Flexitouch Plus |
| Molnlycke Health Care US, LLC | $28.32 | 2025 | Mextra Superabsorbant, Mepitel One, Mepilex Border Post-Op Ag |
| Cumberland Pharmaceuticals, INC. | $27.25 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.30 | 2023 | Delstrigo, Dificid, Pifeltro |
| Paratek Pharmaceuticals, INC. | $24.89 | 2024 | Nuzyra |
| Kerecis Limited | $24.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $22.24 | 2025 | Activ.A.C. |
| Convatec INC. | $19.52 | 2025 | |
| Insmed, INC. | $19.31 | 2024 | Arikayce |
| Integra Lifesciences Corporation | $17.78 | 2025 | Tcc-Ez |
| Next Science LLC | $16.46 | 2024 | Blastx, Xperience, Surgx |
| Janssen Scientific Affairs, LLC | $14.66 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Shook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.